|
||
| |||||||
Pharma License Exchange™ partners with Needle & Rosenberg PC TORONTO, Feb. 10, 2004 – Montalier International Ltd. announced today that it has entered into an agreement with Needle & Rosenberg PC, an IP law firm, for the upcoming Pharma License Exchange™ partnering forum in Washington DC, March 10-11, 2004. The association with Needle & Rosenberg will add an attractive and valuable new element to the partnering forum in that the attendees may benefit from an intellectual property and licensing discussion as an included part of the total conference package. Under the agreement Needle & Rosenberg’s senior shareholder, Mr. David Perryman, will be meeting with interested companies in 30-minute time slots to answer questions and provide information in matters related to IP and licensing.* “The Pharma License Exchange™ partnering forum offers pharma and biotech companies a uniquely efficient chance to explore valuable business development and licensing opportunities and to initiate the deal making process,” says Mr. Perryman. “Basic knowledge of IP issues and strategy are an integral part of efficient deal making. We are pleased to get this opportunity to provide additional value for the Pharma License Exchange™ attendees.” “We are extremely pleased to be able to add this innovative element to the forum. We feel confident that our attendees will see the great value in this and take advantage of the offer,” said Mr. Vidar Bentzen, the CEO of Montalier International Ltd, the organizers of this forum. Mr. Bentzen added: “As a top-ranking intellectual property law firm, Needle & Rosenberg is able to give expert advice and to provide specialized legal services that every pharma and biotech company is in need of to protect and to create value from core assts. Their contribution to the upcoming Pharma License Exchange™ forum is significant.” About Pharma License Exchange™ Pharma License Exchange™ is a twice yearly pharma and biotech partnering forum specializing in one-to-one meetings. It was developed by Montalier International Ltd. to provide an efficient and effective partnering alternative for business development and licensing executives in the pharma and biotech industries. An exceptional ratio of opportunities to time and cost makes it North America’s most efficient partnering forum. During the 2-day forum, each participants may meet with up to 20 companies one-to-one and face-to-face. A well-structured pre-event information exchange, during which the attendees review each other’s profiles and objectives and select their meeting partners, ensures that the meetings are constructive and fruitful. The Pharma License Exchange™ forum gathers a select group of pharma and biotech executives with genuine licensing mandates. Specific admittance criteria ensures that the participants are all there for one, common purpose, namely to explore the best business opportunities and to initiate collaborations. The next partnering forum takes place March 10-11, 2004, at Swissotel The Watergate in Washington DC. Registration is ongoing. Further information: www.pharlex.com About Needle & Rosenberg PC Founded in 1983, this Atlanta-based firm consists of a specialized team of legal and technical experts that live and breathe intellectual property law. They offer a complete resource for intellectual property matters including patents, trademarks, copyrights, trade secrets, licensing and litigation. The firm is often referred to as the largest IP boutique in the south-eastern United States. Mr. David Perryman is a shareholder at Needle & Rosenberg, P.C., and leads the firm's biotechnology practice. He has been exclusively practicing biotech patent law since 1986 and has been with Needle & Rosenberg since 1991. He is admitted to the bar and has practiced biotechnology patent law in California, Georgia and New York. Mr. Perryman is an experienced entrepreneur, having co-founded a number of biotech companies. He currently serves on the board of directors for several companies in the industry. Further information: www.needlerosenberg.com About Montalier International Ltd. Montalier International Ltd. was founded in 1993 to provide business development and licensing services to the pharmaceutical and biotech industries. The traditional and still most significant area of business is efficient international partnership sourcing for individual companies, involving current or new products, delivery and enabling technologies, joint ventures, acquisitions, etc. In addition, the company organizes the Pharma License Exchange™ partnering forum. Montalier is well connected in the global pharma and biotech industries, forging strong and personal relationships with key players resulting from decades of direct professional involvement. Further information: www.montalier.com Contact Mr.
Vidar Bentzen Phone:
416-766-3517 Note: *Attendees taking advantage of this IP opportunity should not disclose confidential information as no attorney-client relationship will be established between the attendees and Needle & Rosenberg. Please forward this news announcement to your friends & colleagues who might find it useful. |
|
| ||||||||